AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Asian Gynecological Brachytherapy Registry in Cervical Cancer

Recruitingn/aAges any - anyFemaleTata Memorial Hospital
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

Gynecological cancer poses as significant public health issue, especially in Asian countries, where it is a leading cause of cancer-related deaths among women. Cervical cancer accounts for around 311,000 deaths annually, with over 85% occurring in low- and middle-income nations, primarily in Asia. Factors contributing to this burden include limited access to preventive care, inadequate screening, high rates of human papillomavirus infection, and cultural barriers that delay medical attention. For patients with advanced cervical cancer, the standard treatment involves external beam radiation therapy along with chemotherapy followed by internal radiation, known as Brachytherapy. This technique uses unique set of devices placed internally at the tumor sitegiving localized radiation to the residual tumor tissue. While advanced brachytherapy techniques have been developed and practiced in Eu

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Patients diagnosed with FIGO 2018 stage IB-IVA cervical cancer with squamous cell carcinoma, adenocarcinoma or adenosquamous carcinoma histological subtype. * Planned for treatment with definitive chemo-radiation and brachytherapy. (X- ray,CT, CT-Ultrasound or MRI based). Exclusion Criteria: * Neuroendocrine cancer of the cervix or other rare histology subtypes. * Patients with metastatic cervix cancer and not planned for radical doses of pelvic RT/brachytherapy may be excluded. * Patients undergoing postoperative RT or RT for recurrent disease should be excluded.
๐Ÿ’Š

What it tests

  • Not listed
๐Ÿ“

Where

5 sites
Tata Memorial Center
Mumbai, India
Gunma University
Maebashi, Japan
Juntendo University
Tokyo, Japan
Mahidol University
Bangkok, Thailand
Chiang Mai University
Chiang Mai, Thailand
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy